- Home/Publications/Pharmaceutical Law Insight
Dear Subscriber,
I would like to inform you of an exciting change to your Pharmaceutical Law Insight subscription which will give you even more valuable content at no extra cost.
This current issue (May 2010) will be the last stand-alone issue of Pharmaceutical Law..
Online Published Date:
10 June 2010
Appeared in issue:
Vol 6 No 5 - 01 May 2010
News in brief
AstraZeneca settles generic Entocort suit
UNITED STATES
Anglo-Swedish drug maker AstraZeneca has reached a settlement with Teva Pharmaceuticals over the marketing of a generic copy of AstraZeneca’s anti-inflammatory drug Entocort (budesonide)...
Online Published Date:
10 June 2010
Appeared in issue:
Vol 6 No 5 - 01 May 2010
US court wants clarification on pay-to-delay settlements
The US Court of Appeals has called on the District Court to revisit a 2005 decision which set the legal precedent to allow so-called ‘pay-to-delay’ deals within the pharmaceutical industry.
These deals involve patent-owning..
Online Published Date:
10 June 2010
Appeared in issue:
Vol 6 No 5 - 01 May 2010
News in brief
Merck settles Zetia patent suit
UNITED STATES
Merck & Co has settled its patent litigation against generic drug firm Glenmark Pharmaceuticals over Merck’s cholesterol lowering drug Zetia (ezetimibe). The case was set to go to trial on 12..
Online Published Date:
10 June 2010
Appeared in issue:
Vol 6 No 5 - 01 May 2010
Report warns of critical time for pharma patents
A looming patent cliff facing major pharmaceutical companies is pushing the industry into a critical phase in terms of drug innovation and consolidation, according to the latest annual life sciences research from IP law firm Marks & Clerk.
The..
Online Published Date:
10 June 2010
Appeared in issue:
Vol 6 No 5 - 01 May 2010
The influence of the Draft Amendment to the Patent Act on biotech patents in Taiwan
Patent Attorneys Yulan Kuo and Frank Lu explore the possibilities of patenting animal and plant subject-matters in Taiwan
Online Published Date:
10 June 2010
Appeared in issue:
Vol 6 No 5 - 01 May 2010
Pharmaceutical patents case clarifies first authorisation
Supplementary Protection Certificate appeal dismissed on reference to European case law
Online Published Date:
10 June 2010
Appeared in issue:
Vol 6 No 5 - 01 May 2010
Pharmaceutical trademarks in the European Union
Mary Spears, attorney at HGF, discusses the special considerations to be taken into account when applying for pharmaceutical trademarks within the EU
Online Published Date:
10 June 2010
Appeared in issue:
Vol 6 No 5 - 01 May 2010
ECJ says rules limiting pharmacies are justified
EU member states are free to limit the establishment of new pharmacies by geographic and demographic considerations as long as they are not discriminatory in applying those rules or prevent the adequate provision of pharmaceutical..
Online Published Date:
10 June 2010
Appeared in issue:
Vol 6 No 5 - 01 May 2010
Patent litigation and doctrine of equivalents
Maria Nilova, managing partner of law firm PATENTICA, discusses the enforcement of IP rights in Russia
Online Published Date:
10 June 2010
Appeared in issue:
Vol 6 No 5 - 01 May 2010
News in brief
German court invalidates GSK Advair patent
GERMANY
A group of generic drug makers have won a patent challenge in a German court against GlaxoSmithKline’s asthma drug Advair (fluticasone/salmeterol). The German Federal Patents Court ruling..
Online Published Date:
10 June 2010
Appeared in issue:
Vol 6 No 5 - 01 May 2010